GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Capex-to-Operating-Income

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Capex-to-Operating-Income : 30.50 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Capital Expenditure for the three months ended in Mar. 2024 was ฿-16.62 Mil. Its Operating Income for the three months ended in Mar. 2024 was ฿0.55 Mil.

Hence, JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 30.50.


JSP Pharmaceutical Manufacturing (Thailand) PCL Capex-to-Operating-Income Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Capex-to-Operating-Income Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
0.53 0.14 0.77 - 86,784.00

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 365.79 - - 3.74 30.50

Competitive Comparison of JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income

For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income falls into.



JSP Pharmaceutical Manufacturing (Thailand) PCL Capex-to-Operating-Income Calculation

JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-173.568) / 0.002
=86,784.00

JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-16.623) / 0.545
=30.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JSP Pharmaceutical Manufacturing (Thailand) PCL  (BKK:JSP-F) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


JSP Pharmaceutical Manufacturing (Thailand) PCL Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Traded in Other Exchanges
N/A
Address
No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines